2020
DOI: 10.1055/s-0040-1712467
|View full text |Cite
|
Sign up to set email alerts
|

Clinicians' Values and Preferences for Medication Adherence and Cost Clinical Decision Support in Primary Care: A Qualitative Study

Abstract: Background Medication nonadherence and unaffordability are prevalent, burdensome issues in primary care. In response, technology companies are capitalizing on clinical decision support (CDS) to deliver patient-specific information regarding medication adherence and costs to clinicians using electronic health records (EHRs). To maximize adoption and usability, these CDS tools should be designed with consideration of end users' values and preferences. Objective This article evaluates primary care clini… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
10
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 43 publications
(50 reference statements)
2
10
0
Order By: Relevance
“…Clinician informational needs and preferences for CDS design is important to optimize acceptance and adherence to CDS recommendations. [26][27][28][29][30] Finally, the relative risk calculations for diLQTS in this investigation were conducted broadly at the drug level across all patients, ignoring the specific patient-level information that may have placed a given patient at greater or lesser risk of diLQTS. Accurate risk prediction of diLQTS is an active area of research in our group, and we anticipate that with improved prediction modeling, a more accurate risk assessment could both improve accuracy of CDS alerts, as well as provide more meaningful guidance for providers at the time of prescription.…”
Section: Limitationsmentioning
confidence: 99%
“…Clinician informational needs and preferences for CDS design is important to optimize acceptance and adherence to CDS recommendations. [26][27][28][29][30] Finally, the relative risk calculations for diLQTS in this investigation were conducted broadly at the drug level across all patients, ignoring the specific patient-level information that may have placed a given patient at greater or lesser risk of diLQTS. Accurate risk prediction of diLQTS is an active area of research in our group, and we anticipate that with improved prediction modeling, a more accurate risk assessment could both improve accuracy of CDS alerts, as well as provide more meaningful guidance for providers at the time of prescription.…”
Section: Limitationsmentioning
confidence: 99%
“… 80 , 81 Patients may not discuss cost unless asked, 82 such as when providers note adherence problems. 23 , 60 Similarly, we found that information about challenges might be elicited only after prescriptions went unfilled. However, some providers reported surfacing cost barriers by routinely asking about cost concerns, particularly those working in the 8 clinical settings that had implemented SDOH screening programs.…”
Section: Discussionmentioning
confidence: 55%
“…Furthermore, although new tools such as RTBTs may address prescribers’ desires for point-of-care tools to recommend alternatives, 60 there has been little attention to the needs and perspectives of a range of providers engaged with addressing patients’ medication affordability challenges, such as pharmacists, nurses, social workers, and advanced practice providers, in designing such tools. Pharmacists assist patients in identifying cost-effective insurance plans 61 , 62 and selecting lower-cost medications.…”
Section: Introductionmentioning
confidence: 99%
“…We designed the alerts to be actionable, provide alternatives, include standardized text, and display at medication selection instead of order signing. 15,16 The prescriber was then allowed to select one of the suggested alternatives, continue with the original order, or cancel the order (►Fig. 1).…”
Section: Methodsmentioning
confidence: 99%